Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Merchavia Holdings and Investments Ltd. (MRHL.TA)
Bnei Brak, IL
Merchavia Holdings and Investments Ltd., founded in 1972 and based in Bnei Brak, Israel, operates as an investment company with a primary focus on the Israeli life sciences industry. Its varied portfolio includes funding and developing numerous cutting-edge medical and healthcare solutions. The company's ventures cover: Innovative diagnostic tools aimed at detecting cancer. Wearable medical equipment, such as smartwatches, bracelets, and patches, equipped with sensor technology for health monitoring and diagnostic purposes. Aura smart air, an intelligent, data-driven system that uses user behavior algorithms and real-time smart sensors to oversee and manage both indoor and outdoor air quality. TrainPain, a digital therapeutic designed to enhance the mental and emotional health of individuals suffering from neuropathic and fibromyalgia pain. RevDx (Revolutionary Diagnostics), a compact, handheld device enabling immediate complete blood count analyses. A rechargeable electric cannabis inhaler, which connects via Bluetooth to the VEOLI App for managing dosages and capsule supply. An artificial intelligence-driven neuromonitoring instrument intended for use in operating rooms to prevent nerve damage during surgery. Additionally, Merchavia is engaged in the creation, manufacturing, and commercialization of women's health products. Notable offerings include Ballerine, a copper-based, hormone-free intrauterine contraceptive device, and a spherical endometrial ablation device currently undergoing Phase IIa clinical trials for treating abnormal uterine bleeding. The company was formerly known as Nepco Star Ltd. until its name officially changed to Merchavia Holdings and Investments Ltd. in November 2014.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.17% | -4.68% | +3.67% | +58.37% | -18.79% | +115.78% | +76.77% | -55.75% | -54.78% | -82.46% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Care Facilities: +10.2%+248.7% ★ Q4'25: -78.9% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%-22.0% Q4'25: +94.2% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-2,430.8% Q4'25: -566.7% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%-2,444.8% Q4'25: -624.4% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%-64.5% Q4'25: -21.4% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+18.1% Q4'25: +36.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-0.07× Q4'25: -0.22× (vs Q4'23)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Eli Arad | Chief Executive Officer | 541.0K | male |
| Ilan Goldstein | President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MRHL.TA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
